Anxo Pharmaceutical Co., Ltd. (6677.TWO)
TWD 24.2
(-0.21%)
TWD 24.2
(-0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 939.94 Million | 866.27 Million | 824.1 Million | 866.11 Million | 877.93 Million |
| Cost of Revenue | 543.01 Million | 534.81 Million | 492.44 Million | 509.81 Million | 558.65 Million |
| Gross Profit | 396.93 Million | 331.45 Million | 331.65 Million | 356.29 Million | 319.27 Million |
| Operating Expenses | 396.93 Million | 325.24 Million | 291.81 Million | 299.17 Million | 273.91 Million |
| Selling, General and Administrative Expenses | 204.57 Million | 185.65 Million | 180.43 Million | 198.61 Million | 207.14 Million |
| Research and Development Expenses | 139.2 Million | 139.58 Million | 111.38 Million | 100.56 Million | 66.73 Million |
| Other Expenses | - | 2.88 Million | -4.12 Million | 5.4 Million | - |
| Cost and Expenses | 886.79 Million | 860.06 Million | 784.25 Million | 808.98 Million | 832.56 Million |
| Operating Income | 53.15 Million | 10.74 Million | 36.83 Million | 63.23 Million | 45.39 Million |
| Interest Expense | 18.07 Million | 15.19 Million | 12.76 Million | 14.18 Million | 16.81 Million |
| Income Tax Expense | 7.88 Million | 2.32 Million | 4.58 Million | 10.3 Million | 7.63 Million |
| Earnings before Tax | 38.68 Million | -4.71 Million | 24.32 Million | 48.91 Million | 29.41 Million |
| Net Income | 21.86 Million | -12.55 Million | 19.23 Million | 31.4 Million | 24.11 Million |
| Earnings Per Share Basic | 0.42 | -0.26 | 0.39 | 0.63 | 0.52 |
| Earnings Per Share Diluted | 0.42 | -0.26 | 0.39 | 0.63 | 0.52 |
| Weighted Average Shares Outstanding | 52.05 Million | 48.16 Million | 49.93 Million | 49.81 Million | 46.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.59 Million | 48.16 Million | 50.26 Million | 49.82 Million | 46.54 Million |
| Gross Margin | 0.42 | 0.38 | 0.40 | 0.41 | 0.36 |
| EBIT Margin | 0.14 | 0.10 | 0.13 | 0.17 | 0.13 |
| Profit Margin | 0.02 | -0.01 | 0.02 | 0.04 | 0.03 |
| EBITDA | 131.31 Million | 84.96 Million | 111.21 Million | 144.24 Million | 117.08 Million |
| Earnings Before Tax Margin | 0.06 | 0.01 | 0.04 | 0.07 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 207.43 Million | 207.43 Million | 247.37 Million | 939.94 Million | 247.37 Million | 222.59 Million |
| Cost of Revenue | 137.49 Million | 137.49 Million | 143.34 Million | 543.01 Million | 143.34 Million | 128.16 Million |
| Gross Profit | 69.94 Million | 69.94 Million | 104.03 Million | 396.93 Million | 104.03 Million | 94.42 Million |
| Operating Expenses | 52.42 Million | 86.26 Million | 87.4 Million | 343.78 Million | 87.4 Million | 84.63 Million |
| Selling, General and Administrative Expenses | 57.26 Million | 57.26 Million | 53.16 Million | - | 53.16 Million | 49.04 Million |
| Research and Development Expenses | 30.19 Million | 30.19 Million | 34.22 Million | - | 34.22 Million | 35.38 Million |
| Other Expenses | -35.03 Million | - | - | -445 Thousand | - | - |
| Cost and Expenses | 189.92 Million | 223.76 Million | 230.74 Million | 886.79 Million | 230.74 Million | 212.79 Million |
| Operating Income | 17.51 Million | -17.51 Million | 16.65 Million | 56.59 Million | 16.65 Million | 9.99 Million |
| Interest Expense | - | - | - | 18.07 Million | - | - |
| Income Tax Expense | 2.76 Million | 2.76 Million | 3.17 Million | 7.88 Million | 3.17 Million | 770 Thousand |
| Earnings before Tax | -18.96 Million | -18.96 Million | 13.49 Million | 38.68 Million | 13.49 Million | 5.84 Million |
| Net Income | -17.56 Million | -17.56 Million | 7.67 Million | 21.86 Million | 7.67 Million | 3.25 Million |
| Earnings Per Share Basic | -0.32 | -0.32 | 0.14 | - | 0.14 | 0.06 |
| Earnings Per Share Diluted | -0.32 | -0.32 | 0.14 | - | 0.14 | 0.07 |
| Weighted Average Shares Outstanding | 55.66 Million | 55.76 Million | 54.28 Million | 52.05 Million | 54.28 Million | 50.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.66 Million | 55.76 Million | 54.07 Million | 51.59 Million | 54.07 Million | 49.1 Million |
| Gross Margin | 0.34 | 0.34 | 0.42 | 0.42 | 0.42 | 0.42 |
| EBIT Margin | -0.01 | 0.01 | 0.13 | - | 0.13 | 0.11 |
| Profit Margin | -0.08 | -0.08 | 0.03 | 0.02 | 0.03 | 0.01 |
| EBITDA | -2.52 Million | 1.41 Million | 31.31 Million | - | 31.31 Million | 25.23 Million |
| Earnings Before Tax Margin | 0.08 | -0.08 | 0.07 | 0.06 | 0.07 | 0.04 |
0JW2
MEOH
BL
CLBTW
AKSI
5871